Publication:
Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation

dc.contributor.authorSpeich, Benjamin
dc.contributor.authorSchur, Nadine
dc.contributor.authorGryaznov, Dmitry
dc.contributor.authorvon Niederhäusern, Belinda
dc.contributor.authorHemkens, Lars G
dc.contributor.authorSchandelmaier, Stefan
dc.contributor.authorAmstutz, Alain
dc.contributor.authorKasenda, Benjamin
dc.contributor.authorPauli-Magnus, Christiane
dc.contributor.authorOjeda-Ruiz, Elena
dc.contributor.authorTomonaga, Yuki
dc.contributor.authorMcCord, Kimberly
dc.contributor.authorNordmann, Alain
dc.contributor.authorvon Elm, Erik
dc.contributor.authorBriel, Matthias
dc.contributor.authorSchwenkglenks, Matthias
dc.contributor.funderFederal Office of Public Health
dc.date.accessioned2019-04-10T11:46:09Z
dc.date.available2019-04-10T11:46:09Z
dc.date.issued2019-01-11
dc.description.abstractBACKGROUND: The preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic. METHODS: We surveyed investigators of RCTs which were approved by RECs in 2012 or in 2016 and asked for RCT preparation costs using a pre-specified item list. Additionally, we collected approval times from RECs and Swissmedic. RESULTS: The response rates of the investigator survey were 8.3% (19/228) for 2012 and 16.5% (47/285) in 2016. The median preparation cost of an RCT was USD 72,400 (interquartile range [IQR]: USD 59,500-87,700; n = 18) in 2012 and USD 72,600 (IQR: USD 42,800-169,600; n = 35) in 2016. For single centre RCTs a median REC approval time of 82 (IQR: 49-107; n = 38) days in 2012 and 92 (IQR: 65-131; n = 63) days in 2016 was observed. The median Swissmedic approval time for any clinical trial was 27 (IQR: 19-51; n = 213) days in 2012 and 49 (IQR: 36-67; n = 179) days in 2016. The total duration for achieving RCT approval from both authorities (REC and Swissmedic) in the parallel submission procedure applied in 2016 could not be assessed. CONCLUSION: Based on limited data the costs to plan and prepare RCTs in Switzerland were approximately USD 72,000 in 2012 and 2016. For effective and valid research on costs and approval times of RCTs a greater willingness to share cost information among investigators and more collaboration between stakeholders with data linkage is necessary.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis project was funded by the Swiss Federal Office of Public Health. The Swiss Federal Office of Public Health was involved in the protocol development for this study; however was not involved in the data collection and analysis, decision to publish, or preparation of the manuscript. Benjamin Speich was supported by the Research Foundation of the University of Basel.es_ES
dc.format.number1es_ES
dc.format.pagee0210669es_ES
dc.format.volume14es_ES
dc.identifier.citationPLoS One. 2019 Jan 11;14(1):e0210669.es_ES
dc.identifier.doi10.1371/journal.pone.0210669es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.pubmedID30633776es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7445
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS)es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0210669es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleResource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislationes_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationccbb00d5-0ada-4968-957f-f8250924cc39
relation.isAuthorOfPublication.latestForDiscoveryccbb00d5-0ada-4968-957f-f8250924cc39

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ResourceUseCostsAnd_2019.pdf
Size:
594.25 KB
Format:
Adobe Portable Document Format
Description: